FDA Approval Summary: Accelerated Approval of Sacituzumab Govitecan-hziy for Third Line Treatment of Metastatic Triple-negative Breast Cancer (mTNBC)
Wahby, Sakar, Fashoyin-Aje, Lola, Osgood, Christy L., Cheng, Joyce, Fiero, Mallorie H., Zhang, Lijun, Tang, Shenghui, Hamed, Salaheldin S, Song, Pengfei, Charlab, Rosane, Dorff, Sarah E., Ricks, TiffaJournal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-20-3119
Date:
November, 2020
File:
PDF, 608 KB
2020
File converter
More search results
More benefits 
